Cervical Cancer Screening Among Adult Women in China, 2010

Baohua Wang, Minfu He, Ann Chao, Michael M Engelgau, Mona Saraiya, Limin Wang, Linhong Wang, Baohua Wang, Minfu He, Ann Chao, Michael M Engelgau, Mona Saraiya, Limin Wang, Linhong Wang

Abstract

Introduction: Cervical cancer is one of the most commonly diagnosed cancers among women in China. The World Health Organization (WHO) recommends routine screening for cervical cancer, and the WHO Global Monitoring Framework suggests that every nation monitors cervical cancer screening. However, little information is available on cervical cancer screening behavior among women in China.

Methods: We used data from the 2010 China Chronic Disease and Risk Factor Surveillance System that included 51,989 women aged 18 years and older. We report the proportion of women who reported ever having had a Papanicolaou (Pap) test, stratified by sociodemographic characteristics and geographic region. Multivariable logistic regression modeling was performed to adjust for potential confounders.

Results: Overall, 21% of 51,989 women reported having ever had a Pap test. The highest proportion was reported among women aged 30-39 years (30.1%, 95% confidence interval, 26.8%-33.4%). In all geographic regions, women in rural areas were consistently less likely than women in urban areas to report having had a Pap test. Among women who reported ever having a Pap test, 82% reported having the most recent test in the past 3 years. Factors associated with reporting ever having a test were being aged 30-49 years, higher education, being married, and having urban health insurance.

Conclusion: Our results indicate that screening programs need to be strengthened along with a more intense focus on specific demographic groups. National cervical cancer screening guidelines and comprehensive implementation strategies are needed to make screening services available and accessible to all women.

Implications for practice: This study is the largest nationwide and population-based assessment of self-reported history of Pap test for cervical cancer screening in China. This article describes cervical cancer screening behavior among women and examines key demographic and geographic factors. Only one fifth of Chinese women reported having ever had a Pap test for cervical cancer screening. The results highlight the urgent need to develop national cervical cancer screening guidelines and strategies that make screening services widely available, accessible, and acceptable to all women, especially to those who reside in rural areas and those with no health insurance.

Keywords: Cervical cancer; China; Epidemiology; Papanicolaou test; Women.

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

©AlphaMed Press.

Figures

Figure 1.
Figure 1.
Location of 162 urban and rural study sites of the China National Disease Surveillance Points System, the 2010 China Chronic Disease and Risk Factor Surveillance.
Figure 2.
Figure 2.
Prevalence and time since last Pap test by urban/rural status (2010 China Chronic Disease and Risk Factor Surveillance). The percentages are weighted to represent the total population of the national disease surveillance points system with poststratification for age and gender. A total of 188 screened subjects were excluded because of missing test time information on time since last Pap test.

References

    1. He J, Chen WQ. 2012 Chinese Cancer Registry Annual Report. Beijing, China. Beijing, People’s Republic of China: Military Medical Science Press; 2012.
    1. World Health Organization . National Cancer Control Programmes: Policies and Managerial Guidelines. 2nd ed. Geneva, Switzerland: World Health Organization; 2002.
    1. World Health Organization (WHO) WHO Guidance Note: Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women. Geneva, Switzerland: World Health Organization; 2013.
    1. Yang G, Hu J, Rao KQ, et al. Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr. 2005;3:3.
    1. Zhou MG, Jiang Y, Huang ZJ, et al. Adjustment and representativeness evaluation of national disease surveillance points system [in Chinese] Dis Surveill. 2010;25:239–244.
    1. National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention . Report on Chronic Disease and Risk Factor Surveillance in China 2010 [in Chinese] Beijing, People’s Republic of China: Military Medical Science Press; 2012.
    1. Wang BH, He MF, Wang LM, et al. Breast cancer screening among adult women in China, 2010. Prev Chronic Dis. 2013;10:130136.
    1. Zhao EF, Bao L, Li C, et al. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50 years [in Chinese] J First Mil Med Univ. 2005;25:605–609.
    1. World Health Organization (WHO). United Nations High-Level Meeting on Noncommunicable Disease Prevention and Control. Available at . Accessed January 6, 2014.
    1. International Agency for Research on Cancer (IARC) Cervix Cancer Screening. Vol 10. Lyon, France: IARC Press; 2005.
    1. Jin XW, Lipold L, McKenzie M, et al. Cervical cancer screening: What’s new and what’s coming? Cleve Clin J Med. 2013;80:153–160.
    1. Chen YC, Tang SC, Le H, et al. Compare health development of rural areas in different districts of China: About social economy and inhabitant’s health condition [in Chinese] Chinese Health Economics. 2006;25:37–38.
    1. Centers for Disease Control and Prevention (CDC) Cancer screening: United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:41–45.
    1. Lee M, Chang HS, Park EC, et al. Factors associated with participation of Korean women in cervical cancer screening examination by age group. Asian Pac J Cancer Prev. 2011;12:1457–1462.
    1. Lin SJ. Factors influencing the uptake of screening services for breast and cervical cancer in Taiwan. J R Soc Promot Health. 2008;128:327–334.
    1. Ulijaszek SJ. Socio-economic status, forms of capital and obesity. J Gastrointest Cancer. 2012;43:3–7.
    1. Kottke TE, Isham GJ. Measuring health care access and quality to improve health in populations. Prev Chronic Dis. 2010;7:A73.
    1. Feng X, Tang S, Bloom G, et al. Cooperative medical schemes in contemporary rural China. Soc Sci Med. 1995;41:1111–1118.
    1. Yu B, Meng Q, Collins C, et al. How does the New Cooperative Medical Scheme influence health service utilization?: A study in two provinces in rural China. BMC Health Serv Res. 2010;10:116.
    1. Qian D, Pong RW, Yin A, et al. Determinants of health care demand in poor, rural China: The case of Gansu Province. Health Policy Plan. 2009;24:324–334.
    1. Tang S, Meng Q, Chen L, et al. Tackling the challenges to health equity in China. Lancet. 2008;372:1493–1501.
    1. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342–362.
    1. Gaffikin L, Blumenthal PD, Emerson M, et al. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project. Lancet. 2003;361:814–820.
    1. Denny L, Kuhn L, De Souza M, et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial. JAMA. 2005;294:2173–2181.
    1. National Health and Family Planning Commission of the People’s Republic of China. The Technical Solution of Cervical Cancer Screening for Chinese Rural Women 2009 [in Chinese]. Available at . Accessed January 6, 2014.
    1. Sankaranarayanan R, Nene BM, Dinshaw KA, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005;116:617–623.
    1. Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: A cluster-randomised trial. Lancet. 2007;370:398–406.
    1. World Health Organization (WHO). WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention 2013. Available at . Accessed January 9, 2015.
    1. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst. 2012;104:178–188.
    1. Zhao FH, Tiggelaar SM, Hu SY, et al. A multi-center survey of age of sexual debut and sexual behavior in Chinese women: Suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol. 2012;36:384–390.
    1. Wu EQ, Liu B, Cui JF, et al. Prevalence of type-specific human papillomavirus and pap results in Chinese women: A multi-center, population-based cross-sectional study. Cancer Causes Control. 2013;24:795–803.
    1. Gu C, Chan CW, Twinn S. How sexual history and knowledge of cervical cancer and screening influence Chinese women’s screening behavior in mainland China. Cancer Nurs. 2010;33:445–453.
    1. Spadea T, Bellini S, Kunst A, et al. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: A review. Prev Med. 2010;50:159–164.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere